Kemampuan Siswa Dalam Menyelesaikan Soal-soal Uraian Terstruktur Pokok Bahasan Teori Kinetik Gas

"> Penelitian ini bertujuan untuk mengetahui (1) kemampuan kognitif yang dilihat dari hasil belajar peserta didik yang kelas XI MAN Model Palangka Raya dalam mengerjakan soal-soal uraian terstruktur pada pokok bahasan Teori Kinetik Gas; dan (2) kesulitan peserta didik dalam mengerjakan soal-soal uraian terstruktur. Penelitian ini menggunakan metode penelitian kuantitatif dalam mengumpulkan datanya. Penelitian ini menggunakan instrumen dalam bentuk soal uraian terstruktur. Hasil uji coba soal uraian terstruktur pada kelas XI IA-1 MAN Model Palangka Raya mendapatkan tingkat validitas rata-rata 0,536 dan tingkat reliabilitas soal 0,539 dengan kategori cukup. Hasil penelitian menunjukkan bahwa: (1) peserta didik yang mampu dan tidak mengalami masalah dalam mengerjakan soal-soal uraian terstruktur berjumlah 18 peserta didik dan 12 peserta didik tidak mampu dan mengalami masalah dalam mengerjakan soal-soal uraian terstruktur. Peserta didik yang mampu mengerjakan soal-soal uraian terstruktur memiliki ketuntasan belajar ≥ batas KKM, yaitu 60% (2) kesulitan peserta didik dalam mengerjakan soal-soal uraian terstruktur terdapat pada penyebutan dan penulisan satuan besaran pada jawaban dengan persentase kesulitan 36,7%, penguasaan operasi hitungan denganpersentase kesulitan 31,4% dan penulisan besaran yang ditanya dalam soal dengan persentase kesulitan 28,6%

Research capacity-building for clinicians: Understanding how the research facilitator role fosters clinicians’ engagement in the research process

Background: There is evidence reporting more positive outcomes from research capacity-building (RCB) programmes that include a research facilitator role. Further, it has been suggested that research facilitator roles can be a useful strategy in building the research capacity of healthcare clinicians. However, until now, little attention has been applied to identifying the characteristics of the research facilitator role and how this role contributes to clinicians’ engagement with the research process. The aim of this present study is to explore the characteristics required of the research facilitator role in the educational workshop phase of an RCB programme. Methods: This qualitative study employed an inductive approach and utilized face-to-face interviews to gather data from a purposely selected cohort. Professionally transcribed responses were thematically analysed. Results: The role of the research facilitator emerged as comprising two main themes: (1) facilitating the research process and (2) engaging expert clinicians as novice researchers. Pragmatically, analysis of data led to the development of a table outlining the responsibilities, skills and attributes related to each theme. Conceptually, theme 1 encapsulates the research facilitators’ skills and experience and their role as knowledge brokers and cocreators of knowledge. Theme 2 provides insight into the clinician-centric approach the research facilitators utilized to build and foster relationships and support the clinicians through their research journey. Conclusion: This study reports on the characteristics of the research facilitator role in one phase of an RCB programme in one regional health service district in Australia and explains how the role fosters clinicians’ engagement with the research process. Findings from this study will inform the development of future RCB programmes, which is important considering that clinicians’ increased engagement with the research process is vital for developing a sound evidence base to support decision-making in practice and leads to higher levels of skills and greater ability to perform useful research

Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties – From an efficient <i>E</i>. <i>coli</i> expression system to a pharmaceutical formulation - Fig 4

<p><b>a-d. The influence of multiple dose administration of tested insulin analogs (GKR, GEKR, SR and AKR) positive (insulin glargine or insulin detemir) and negative (0.9% NaCl) controls on glucose concentration in streptozotocin-induced diabetic rats, together with the period after termination of analogs administration. Mean glycemia (± SEM).</b> Star–statistical significance (p<0.05) confirmed in a Newman-Keuls between one of the tested groups (GKR, GEKR, SR or AKR) and a negative control group (0.9% NaCl) at the individual sampling time point. Diamond–statistical significance (p<0.05), confirmed in a Newman-Keuls test during the administration period or in a t-test after stopping insulin administration, between one of the tested groups (GKR, GEKR, SR or AKR) and a positive control (insulin glargine or detemir) at the individual sampling time point. N–Number of tested animals per group.</p

The construction scheme for the expression plasmid pIBAINS.

<p>The resulting expression plasmid pIBAINS contains a hybrid protein SOD::INS gene under the control of the <i>deoP1P2</i> promoter. Abbreviations used: Amp^R, ampicillin resistant; Tet^R, tetracycline resistant; trpA—transcription terminator trpA; SOD, superoxide dismutase gene; A chain, B chain—chains of human insulin gene; ORI, replication origin.</p

The schematic structure of human insulin.

<p>The schematic structure of human insulin.</p

Chemical stability of drug product of insulin analogs during storage at 37°C: Formation of related proteins (content of related proteins in total including desamido A21).

<p>Chemical stability of drug product of insulin analogs during storage at 37°C: Formation of related proteins (content of related proteins in total including desamido A21).</p

Physicochemical properties of insulin analogs.

<p>Physicochemical properties of insulin analogs.</p

Chemical stability of drug product of insulin analogs during storage at 37°C: Formation of covalent dimers and polymers (content of covalent dimers and polymers in total).

<p>Chemical stability of drug product of insulin analogs during storage at 37°C: Formation of covalent dimers and polymers (content of covalent dimers and polymers in total).</p

Nucleotide sequences of primers used for the point mutagenesis reaction.

<p>Nucleotide sequences of primers used for the point mutagenesis reaction.</p

Changes in amino acid sequence in new insulin analogs in reference to human insulin.

<p>Changes in amino acid sequence in new insulin analogs in reference to human insulin.</p